Viewing Study NCT03080805


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-04-24 @ 4:32 PM
Study NCT ID: NCT03080805
Status: UNKNOWN
Last Update Posted: 2020-06-18
First Post: 2017-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE)
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module